A U.S. Senate committee voted on Wednesday to advance President Donald Trump's nominee Howard Lutnick, billionaire chairman ...

Cantor Fitzgerald reaffirmed its Overweight rating and $14.00 price target for Skye Bioscience shares, traded on NASDAQ: SKYE. This target sits at the lower end of the analyst range, with InvestingPro ...

The Cantor Fitzgerald chair was grilled about prior bullish statements made about Tether during a recent Senate hearing.

Howard Lutnick, the chairman of Cantor Fitzgerald and nominee for U.S. Commerce Secretary, faced questioning from Senate Democrats regarding the financial firm's investment in Tether, the entity ...

Stratasys (NASDAQ:SSYS – Get Free Report)‘s stock had its “overweight” rating reiterated by analysts at Cantor Fitzgerald in a note issued to investors on Monday,Benzinga reports. They currently have ...

Cantor Fitzgerald CEO and Commerce Secretary nominee Howard Lutnick became visibly emotional at his confirmation hearing ...

Seventh Circuit upholds forfeiture-for-competition provision in restricted stock unit agreement - A Seventh Circuit panel, in ...

Cantor Fitzgerald raised the firm’s price target on PTC Therapeutics (PTCT) to $113 from $76 and keeps an Overweight rating on the shares. PTC ...

Cantor Fitzgerald has a convertible bond with Tether, incoming Commerce Secretary Howard Lutnick said at his confirmation hearing, confirming previous reporting by The Wall Street Journal that ...

Equities research analysts at Cantor Fitzgerald lifted their FY2025 earnings per share (EPS) estimates for KLA in a note issued to investors on Friday, January 31st. Cantor Fitzgerald analyst C. Muse ...

Howard Lutnick, President Donald Trump's nominee for Commerce Secretary and CEO of Cantor Fitzgerald, says the firm has no ...

In terms of valuation, 4D Molecular Therapeutics Inc’s market capitalization stands at $273.67 million. Market cap represents the total value of all outstanding shares and is a key indicator of a ...